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Abstract
Background: Contrast agents are used in resting echocardiography to opacify the left ventricular (LV) cavity and to
improve LV endocardial border delineation in patients with suboptimal image quality. If a wider use of contrast-
enhanced echocardiography would be adopted instead of the current selective approach, diagnoses such as
myocardial ischemia and LV structural abnormalities could potentially be detected earlier. The aim was therefore to
retrospectively investigate if contrast-enhanced echocardiography beyond the current recommendations for
contrast agent usage affects assessment of wall motion abnormalities, ejection fraction (EF) and detection of LV
structural abnormalities. A secondary aim was to evaluate the user dependency during image analysis.
Methods: Experienced readers (n = 4) evaluated wall motion score index (WMSI) and measured EF on greyscale
and contrast-enhanced images from 192 patients without indications for contrast-enhanced echocardiography.
Additionally, screening for LV structural abnormalities was performed. Repeated measurements were performed in
20 patients by the experienced as well as by inexperienced (n = 2) readers.
Results: Contrast analysis resulted in significantly higher WMSI compared to greyscale analysis (p < 0.003). Of the 83
patients, classified as healthy by greyscale analysis, 55 % were re-classified with motion abnormalities by contrast
analysis. No significant difference in EF classification (≥55 %, 45–54 %, 30–44 %, < 30 %) was observed. LV structural
abnormalities, such as increased trabeculation (n = 21), apical aneurysm (n = 4), hypertrophy (n = 1) and thrombus
(n = 1) were detected during contrast analysis. Intra- and interobserver variability for experienced readers as well as
the variability between inexperienced and experienced readers decreased for WMSI and EF after contrast analysis.
Conclusions: Contrast-enhanced echocardiography beyond current recommendations for contrast agent usage
increased the number of detected wall motion and LV structural abnormalities. Moreover, contrast-enhanced
echocardiography increased reproducibility for assessment of WMSI and EF.
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Background
Accurate assessment and high reproducibility of left ven-
tricular (LV) volumes, ejection fraction (EF), and myo-
cardial wall motion are important factors for diagnosis
of cardiac diseases [1, 2]. Cardiac ultrasound (echocardi-
ography) is currently the most widely used imaging
modality in cardiac diagnostic imaging due to high cost
effectiveness, wide availability in hospitals, generation of
real-time images, non-ionization radiation and high
feasibility. On the other hand, the image quality is sub-
optimal in some patients, which leads to relatively low
accuracy and reproducibility compared to analysis based
on magnetic resonance images in these cases [3]. To
overcome this problem, it has been demonstrated that
the introduction of a contrast agent during echocardiog-
raphy improves endocardial border delineation, and
hence improves the accuracy of LV volume and EF
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measurements as well as myocardial wall motion score
index (WMSI) evaluations [4, 5]. Moreover, contrast-
enhanced echocardiography has shown to reduce inter-
and intraobserver variability [4, 6].
Current guidelines from both the European and
American Societies (European Association of Cardiovascu-
lar imaging (EACVI) and American Society of Echocardi-
ography (ASE)) recommend the use of contrast-enhanced
echocardiography in patients with suboptimal image qual-
ity or when there is a suspicion of structural abnormalities
[7, 8]. In spite of these recommendations, there appears to
be an underuse of contrast agents during echocardio-
graphic examinations. It has been proposed that approxi-
mately 10 to 15 % of all cardiac patients have indications
for contrast-enhanced echocardiography [5, 6]. Neverthe-
less, a recent study [9] demonstrated that only 3.8 % of the
echocardiographic examinations included a contrast agent
during image acquisition. The underuse of contrast agent
in clinical practice may alter the diagnosis and treatment
strategies for the patients, as diagnostic indications can be
omitted. It can be hypothesized that if a wider use of
contrast-enhanced echocardiography would be adopted in-
stead of the current selective approach, diagnoses such as
myocardial ischemia and LV structural abnormalities may
be detected earlier. Moreover, routine use of a contrast
agent during echocardiography in all patients might also
reduce the user dependency during image analysis, as the
image quality increases, not only in patients with sub-
optimal image quality, but also in patients with good
image quality without current indications for contrast-
enhancement. The aim of this study was therefore to
retrospectively investigate if contrast agent usage during
echocardiography beyond the current recommendations af-
fects the evaluation of cardiovascular function with respect
to: 1) Assessment of regional wall motion abnormalities, 2)
EF classification, and 3) Detection of LV structural ab-
normalities. A secondary aim was to evaluate if
contrast-enhanced echocardiography reduced the in-
ter- and intraobserver variability on LV volume and
EF measurements as well as WMSI evaluations, irre-




This retrospective study included patients who were re-
ferred to stress echocardiography from January 2013 to
February 2014 at the Karolinska University Hospital in
Huddinge (The heart clinic), Sweden. This patient group
was selected as the image protocol at our institution
routinely involves analysis of both greyscale and
contrast-enhanced images both at rest and during stress,
regardless of image quality. This enables a comparison
of the diagnostic outcome between greyscale and
contrast-enhanced images at rest in the subset of pa-
tients beyond the current recommendations for contrast
agent usage in standard echocardiography. Note that the
greyscale images routinely are acquired with such quality
that deformation analysis using speckle tracking is feas-
ible during rest and stress. The image acquisition was
performed with a GE Vivid E9 (GE Healthcare, Wiscon-
sin, USA), at a transmitted frequency of 1.5–1.7 MHz.
All contrast-enhanced images were acquired at a low MI
index using contrast specific image sequences, such as
pulse inversion. SonoVue® (Bracco Diagnostics Inc.,
Switzerland) (n = 187) and Optison® (GE Healthcare,
Wisconsin, USA) (n = 5) were used as contrast agents.
The exclusion criteria were based on the recommen-
dations for contrast agent usage during standard echo-
cardiography [7, 8]. Patients were excluded if they
fulfilled the criteria for contrast-enhanced echocardiog-
raphy, i.e. two or more contiguous LV segments not vi-
sualized on a greyscale image or suspicion of LV
structural abnormalities, such as apical hypertrophic car-
diomyopathy, ventricular non-compaction, thrombus or
ventricular pseudoaneurysm. Experienced echocardiog-
rapher (n = 4, 3–15 years of experience) of contrast-
enhanced echocardiography visually evaluated whether
patients should be included in the study or not. Add-
itionally, patients were excluded if any apical 2 chamber
(ch), 3ch or 4ch images in either greyscale or contrast
mode were missing. The study protocol was approved by
the regional ethical review board in Stockholm, Sweden.
Image analysis
The flow chart of the image analysis is shown in Fig. 1.
For all patients included, two image sequences (greyscale
images, greyscale + contrast images) were prepared for
each patient. The latter image sequence contained both
modes to support the evaluation of LV structural abnor-
malities, but only the contrast images in this sequence
were used during WMSI and EF assessment. Before
image analysis was initiated, all patient data were anon-
ymised. The image analyses were allocated between four
experienced readers and the readers evaluated the two
image sequences of one patient with a minimum of two
days apart (greyscale images, greyscale + contrast im-
ages). Furthermore, repeated analyses were performed
on five patients for each of the experienced readers, who
were blinded to previous results. To assess the interob-
server variability, these five patients were also analyzed
once by another experienced reader. Moreover, the vari-
ability between readers with different experience level
was evaluated by letting two inexperienced readers do
repeated analyses on the same twenty patients as the
ones being re-evaluated by the experienced readers. The
inexperienced reviewers had less than 0.5 years of ex-
perience of analyzing echocardiographic images. Prior to
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initiation, the inexperienced readers received a demon-
stration of the image analysis process.
Assessment of wall motion
From apical 2ch, 3ch and 4ch views, WMSI was ob-
tained by dividing the LV using an 18 segment model
[10]. Each segment was assigned a wall motion score
(WMS) depending on the myocardial thickening and
movement pattern. A normally contracting segment was
graded as 1, hypokinesia as 2, akinesia as 3 and dyskin-
esia as 4. A segment was given NA if evaluation of that
specific segment was not applicable due to insufficient
image quality.
LV volume measurements
Left ventricular end-diastolic volume (EDV), left ventricu-
lar end-systolic volume (ESV) and EF were measured in
one cardiac cycle using the biplane method of disks sum-
mation (the modified Simpson’s rule) in EchoPAC (GE
Healthcare, Wauwatosa, WI, USA). End-diastole was visu-
ally defined as the maximal cavity area following mitral
valve closing, whereas end-systole was defined as the min-
imal cavity area preceding mitral valve opening. In accord-
ance with the recommendations from EACVI and ASE,
papillary muscle and trabeculations were excluded from
the cavity during tracing [10].
Detection of LV structural abnormalities
The contrast-enhanced images (3 images/patient) were
screened for LV structural abnormalities such as apical
hypertrophic cardiomyopathy, ventricular non-compaction,
thrombus and ventricular pseudoaneurysm. The screening
for LV structural abnormalities was only conducted by the
experienced readers. Note that patients, who showed struc-
tural abnormalities on the greyscale images, were already
excluded from the study since they had indication for
contrast-enhanced echocardiography.
Statistics
Data analysis was performed using the statistical soft-
ware IBM SPSS Statistics 19 (Armonk, New York, USA).
Age, blood pressure, LV volumes and EF were classified
as continuous data and expressed with mean and stand-
ard deviation. Paired Student t test (95 % confidence
level) was used to compare numerical groups. WMSI for
each patient was determined by calculating the sum of
all WMS divided by the number of visualized segments
[10]. Paired Student t test (95 % confidence level) was
used to compare WMSI before and after contrast. Pa-
tients were categorized according to reference values of
EF: ≥ 55 % reference range, 45–54 % mildly abnormal,
30–44 % moderately abnormal, < 30 % severely abnor-
mal [10]. Additionally, the difference in EF classification
Fig. 1 Schematic illustration of the image analysis process
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between greyscale and contrast image analysis was inves-
tigated using McNemar test. Intra– and interobserver
variability for WMSI and EF measurements was assessed




In total, 321 patients referred for stress echocardiog-
raphy at the Karolinska University Hospital in Huddinge,
Sweden, were screened for the study. After the review
process, 192 patients were included in the patient group,
whereas 129 patients were excluded due to insufficient
image quality (80), allergy to contrast agent (1), absence
of at least one apical image view (30), suspicions of non-
compaction (10), thrombus (7) or hypertrophic cardio-
myopathy (1). Patient characteristics of the patient group
included in the study are presented in Table 1.
Image analysis
Assessment of wall motion
Table 2 shows a comparison of all segments’ WMS for
greyscale and contrast images. As can be seen, the ability
to perform quantitative analysis was considerably im-
proved with contrast, as the number of unanalyzed seg-
ments reduced from 169 (4.9 %) to 14 (0.4 %) segments
when evaluating contrast images instead of greyscale im-
ages. Compared to greyscale analysis, 432 segments were
classified with higher WMS (NA segments not included)
after contrast analysis. Of these segments, the most fre-
quently observed change in WMS was a shift from nor-
mal to hypokinesia. Furthermore, 255 segments were
classified with lower WMS after contrast analysis com-
pared with greyscale analysis.
When investigating WMSI at patient level, the WMSI
obtained after analysis of contrast-enhanced images was
significantly higher compared to greyscale image analysis
(WMSI = 1.23 vs. WMSI = 1.29 p < 0.003). This corre-
sponds to 99 patients having increased WMSI, 42 patients
having decreased WMSI and 51 patients with no change
after contrast analysis (Fig. 2). For those patients with in-
creased WMSI after contrast analysis, higher WMS was
observed in 23 % (SD 15 %) of the segments that were vi-
sualized during greyscale analysis. Additionally, for those
patients with decreased WMSI after contrast analysis,
lower WMS was observed in 29 % (SD 15 %) of the visual-
ized segments during greyscale analysis.
Of the 192 patients included in the study, 83 patients
(43 %) were classified with normal wall motion after image
analysis on greyscale images, i.e. WMS = 1 for every seg-
ment. Patients with NA segments were not included in
these 83 patients, implying that, based on greyscale ana-
lysis, these patients were observed without wall motion
abnormalities. After image analysis of contrast-enhanced
images, 46 (55 %) of these patients were reclassified with
abnormal wall motion (Fig. 2). 125 segments with abnor-
mal wall motion were identified in the left anterior de-
scending (LAD) regions, 25 segments were identified in
the right coronary artery (RCA) regions and 51 segments
were identified in the circumflex (CX) coronary artery re-
gions [10]. Segments with variable perfusion (RCA/CX,
LAD/CX and RCA/LAD) were counted twice. In average,
18 % (SD 10 %) of the segments in the LV received in-
creased WMS after contrast analysis in these patients.
LV volume measurements
There was a significant difference in LV volumes be-
tween greyscale and contrast-enhanced image analysis.
Both EDV and ESV were increased during presence of
contrast agent, see Table 3.
Table 4 shows a comparison of the patients’ EF classifi-
cation for greyscale and contrast-enhanced images. As
can be seen, a majority of the patients (139 patients
(72 %)) remained in the same diagnostic range for both
imaging modes. For the rest of the patients, there was a
trend towards higher EF (30 patients (15 %) compared
with 23 patients (12 %)) after contrast analysis. As Fig. 3
Table 1 Patient characteristics
Age (years) 65 ± 13
Sex (female/male) 62/130
BMI (kg/m2) 27 ± 4a
Systolic blood pressure (mmHg) 133 ± 23b
Diastolic blood pressure (mmHg) 73 ± 11b
Indication for stress echocardiography
Ischemic heart disease 171 (89 %)
Low-flow/low-gradient aortic stenosis 5 (3 %)
Ischemic heart disease and low-flow/low-
gradient aortic stenosis
6 (3 %)
Follow-up heart transplantation 9 (5 %)
Arrhythmia 1 (<1 %)
Patient characteristics of the patient group included in the study (n = 192).
Continuous variables are expressed as mean ± standard deviation
a =mean from 182 patientsb = mean from 137 patients
Table 2 Wall motion score
WMS – Contrast
WMS - Greyscale NA 1 2 3 4
NA 6 120 35 6 2
1 6 2311 345 27 0
2 2 185 207 44 6
3 0 27 38 73 10
4 0 1 2 2 1
Distribution of the myocardial segment wall motion score (WMS) (1-4 or NA)
obtained for greyscale and contrast-enhanced image analysis by
experienced readers
NA not applicable, 1 normal, 2 hypokinesia, 3 akinesia, 4 dyskinesia
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shows, there was no significant difference in EF classifi-
cation between the two imaging modes.
Detection of LV structural abnormalities
The contrast-enhanced images revealed increased tra-
becula formations within the LV in 21 patients, indicat-
ing an enhanced risk of non-compaction. Moreover,
apical aneurysms were detected in four patients, while
hypertrophy and apical thrombus were detected in one
patient each.
Variability analysis
Contrast-enhancement image analysis improved the
agreement for all three conditions of variability for both
WMSI and EF analysis, see Table 5. The improvement
was most pronounced for WMSI evaluations performed
by different experienced readers, with a change from
0.61 to 0.87 after contrast agent injection.
Discussion
The main finding from this study was that contrast-
enhanced echocardiography significantly altered the as-
sessment of cardiac function compared with greyscale
echocardiography, in a patient group specifically selected
due to not having an indication for contrast enhancement.
This was mainly driven by an improved detection of re-
gional wall motion abnormalities, evidenced by the fact
that WMSI was significantly higher after contrast analysis
compared with greyscale analysis. This was further evident
when only considering patients (n = 83) with normal wall
motion (WMS= 1) and sufficient greyscale image quality
(no NA segments) in every segment, where as much as
55 % of these patients, previously classified without wall
motion abnormalities, were re-classified having regional
wall motion abnormalities after contrast-enhanced ana-
lysis. Keeping in mind that the addition of contrast agent
also allowed for detection of LV structural abnormalities
in 27 patients, emphasizes that a broader use of contrast-
enhanced echocardiography can contribute to earlier de-
tection of cardiovascular diseases.
Compared to these previous studies, the present study
strictly selected patients without indications for contrast
agent usage during standard echocardiography. Conse-
quently, the clinical effect of contrast-enhanced echocar-
diography could be determined in patients without
contrast indications. To our knowledge, this is the first
study that investigates the potential benefits of contrast-
enhanced echocardiography beyond current recommen-
dations for resting echocardiography. Even though the
image quality of the included patients would be consid-
ered sufficient for image analysis according to today’s
guidelines of echocardiography (i.e. excluded if two or
more contiguous segments were not visualized on
greyscale images), the number of not visualized seg-
ments were remarkably reduced from 169 segments to
14 segments when using contrast. However, it should be
Fig. 2 The change in wall motion score index (WMSI) when comparing contrast analysis with greyscale analysis for the whole patient group (left)
and the subgroup without wall motion abnormalities (right)
Table 3 Volume measurements
EDV greyscale vs EDV contrast (ml) 98 ± 38 vs 119 ± 44*
ESV greyscale vs ESV contrast (ml) 46 ± 29 vs 53 ± 37*
EF greyscale vs EF contrast (%) 56 ± 12 vs 59 ± 14*
Mean left ventricular volumes and EF obtained after image analysis (n = 192).
Significant difference (p < 0.05) between greyscale and contrast-enhanced
images is marked with*
EDV end-diastolic volume, ESV end-systolic volume, EF ejection fraction
Table 4 Ejection fraction
EF – Contrast
EF - Greyscale ≥55 % 45–54 % 30–44 % <30 %
≥55 % 112 12 4 0
45–54 % 14 13 4 0
30–44 % 4 8 9 3
<30 % 0 0 4 5
Distribution of the measured ejection fraction (EF) for each patient for
greyscale and contrast-enhanced image analysis by experienced readers
EF ejection fraction
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noted that the most common WMS shift for those NA
segments was a change to normal wall motion after con-
trast analysis (71 % of the segments), implying that im-
proved detection of wall motion abnormalities for
contrast-enhanced images is not only restricted to seg-
ments with poor image quality, and that decreased re-
gional wall motion indeed can be more evident using
contrast even when the endocardial border is considered
well visualized. This is not surprising considering the ex-
tremely strong enhancement of the endocardial border
and detailed visualization of trabecula due to the max-
imal separation of cavity and myocardium in white and
black respectively in the contrast-enhanced images.
There was a significant difference in LV volumes and
EF between the different imaging modes, with larger vol-
umes and EF obtained for contrast-enhanced images. It
is well known that LV volumes are underestimated when
analyzing two-dimensional greyscale images, as the areas
between the trabecula within the LV are excluded from
the measurements, and that geometrical assumptions
are made [11]. Suboptimal image quality can also result
in underestimated LV volumes as boundary detection
becomes difficult. On the other hand, the difference in
measured volumes between greyscale and contrast ana-
lysis had no significant impact on patient level, where
most patients remained within the same EF classification
(≥ 55 %, 45–54 %, 30–44 %, < 30 %). The relatively large
EF intervals as well as the fact that both EDV and ESV
were underestimated on greyscale images are possible
explanations for these results.
The results from the study indicate improved reprodu-
cibility for WMSI and EF measurements when using
contrast images instead of greyscale images, which is in
line with previous findings in patients with mixed image
quality [4–6]. In our study, there was a sustained im-
proved reproducibility even in this group with selected
image quality. The improved reproducibility was ob-
served both for repeated measurements by experienced
readers and by in-experienced readers. Accordingly, con-
trast administration during echocardiography can there-
fore be suggested as a complement to minimize the user
dependency of image analysis. This suggestion has also
been purposed previously [4].
It has been reported in literature that approximately
10 to 15 % of all cardiac patients have indications for
contrast-enhanced echocardiography [5, 6]. Following
current recommendations, as much as 34 % of the ex-
aminations were actually excluded from this study due
to being judged to have indication for contrast-enhanced
echocardiography. One possible explanation is that this
study was performed at a center with high contrast
agent usage where the barrier to classify images as
Fig. 3 Distribution of patients according to their ejection fraction (EF). Dark grey bars represent the distribution for greyscale images whereas light grey
bars represent the distribution for contrast-enhanced images. NS indicates a non-significant distribution between the different imaging modes
Table 5 Variability analysis
Experienced readers
analysis 1 vs analysis 2
Experienced readers




WMSI (n = 20) (n = 20) (n = 40)
Greyscale 0.89 0.61 0.58
Contrast 0.94 0.87 0.81
EF (n = 20) (n = 20) (n = 40)
Greyscale 0.90 0.80 0.77
Contrast 0.98 0.95 0.94
Intra-class correlation coefficient for wall motion score index (WMSI) and ejection fraction (EF)
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suboptimal is potentially lower than for a center with
less experience of contrast-enhanced echocardiography,
leading to increased exclusion rates.
The retrospective approach of the present study, where
an objective gold standard, or alternative imaging modality
to confirm the findings of regional wall motion abnormal-
ity interpretation is lacking, is a limitation. However, it
should be kept in mind the contrast-enhanced imaging is
known to improve diagnostic confidence and that several
studies have shown that the results from the image ana-
lysis based on contrast-enhanced images correlate well
with other imaging methods [4, 12–14]. Additionally, a re-
view of the results from previous stress echocardiography
and/or coronary angiography examinations have been per-
formed in a subgroup of patients (n = 46 patients) where a
shift from normal wall motion (WMS= 1 in every seg-
ment) to abnormal wall motion was observed when com-
paring greyscale and contrast analysis. In total, 22 of these
patients were confirmed with myocardial ischemia or in-
farction. When combining the results from the contrast
analysis at rest in the present study with previous studies,
it was concluded that the wall motion abnormalities over-
lapped with the diseased areas in 21 patients out of these
22 patients. This confirms that the observed shift in wall
motion abnormalities in the present study after contrast
analysis may indeed alter the outcome for the patients and
improve the diagnostic power of resting echo, even in pa-
tients with excellent image quality. Another limitation
with the present study is the over representation of pa-
tients with ischemic cardiac disease. This is not a true rep-
resentation of the patient cohort normally referred to
echocardiography. In fact, this is a pilot study and we are
about to perform a prospective randomized study in order
to study the true potential benefit of routine contrast
agent use.
This study is a potential first step towards a broader
use of contrast-enhanced echocardiography instead of
the selective approach used today. From a patient safety
perspective it should be kept in mind that contrast-
enhanced echocardiography is probably one of the best
validated techniques, because of strict protocols and
completely blinded readings required for approval of
contrast agents [15]. The contrast agents approved for
clinical use are well tolerated, and serious adverse reac-
tions are seldom observed [16–18]. Adverse events are
in most cases minor (e.g. headache, nausea, altered taste,
sensation of heat) and self-resolving. Moreover, the risk
for cavitation during ultrasound exposure is limited by
applying imaging settings with a mechanical index lower
than 0.5. Thus for the individual patient, there is a minor
risk to broadening the clinical use of ultrasound contrast
agents. The major barrier to overcome is probably more
related to the clinical reality, where several obstacles
have been pointed out for increased implementation of
contrast use, such as absence of experienced specialists,
training and accreditation for sonographers to independ-
ently perform contrast-enhanced echocardiography [9].
Conclusions
This study showed that contrast-enhanced echocardiog-
raphy beyond the current recommendations for contrast
agent usage indeed affects assessment of cardiovascular
function, in this particular study evidenced by an in-
creased number of detected wall motion and LV struc-
tural abnormalities during contrast analysis compared
with greyscale analysis. Moreover, contrast-enhancement
increased reproducibility for assessment of WMSI and
EF measurements in the settings of this study. A pro-
spective study, evaluating the full potential of a more
widespread use of contrast agent instead of the current
selective approach, is of considerable interest in terms of
patient outcomes and increased cost-effectiveness.
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